Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 2/20 | 0.34 |
| ▸ | CES2 | O00748 | 1/20 | 0.31 |
| ▸ | CES1 | P23141 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 4/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.30 |
| ▸ | TP53 | P04637 | 2/20 | 0.30 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.30 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | CA1 | P00915 | 1/20 | 0.30 |
| ▸ | CA2 | P00918 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
| ▸ | NAAA | Q02083 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL27548537 | 0.98 | EPHX1 (0.33) | EPHX1CES2CES1CYP2C19 | |
| SCHEMBL27905749 | 0.98 | EPHX1 (0.31) | EPHX1TSHRALDH1A1TP53HIF1A | |
| SCHEMBL11658796 | 0.78 | EPHX1 (0.45) | EPHX1CYP2C19CA1CA2NAAA | |
| SCHEMBL439330 | 0.78 | EPHX1 (0.45) | EPHX1CYP2C19CA1CA2NAAA | |
| SCHEMBL29387319 | 0.78 | EPHX1 (0.45) | EPHX1CYP2C19CA1CA2NAAA | |
| SCHEMBL33402 | 0.78 | EPHX1 (0.45) | EPHX1CYP2C19CA1CA2NAAA | |
| SCHEMBL437640 | 0.78 | EPHX1 (0.45) | EPHX1CYP2C19CA1CA2NAAA | |
| SCHEMBL18823065 | 0.78 | EPHX1 (0.45) | EPHX1CYP2C19CA1CA2NAAA | |
| SCHEMBL18823067 | 0.78 | EPHX1 (0.45) | EPHX1CYP2C19CA1CA2NAAA | |
| SCHEMBL645382 | 0.78 | EPHX1 (0.45) | EPHX1CYP2C19CA1CA2NAAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-104342080-B | Adhesive composite, circuit connection material, circuit connection structure and bonding agent sheet material | 日立化成株式会社 | 2019-03-08 | — | — | CN | disclosed |
| CN-104342080-A | Adhesive composition, circuit connecting material, circuit connection structure, and adhesive sheet | HITACHI CHEMICAL CO LTD | 2015-02-11 | — | — | CN | disclosed |
| US-8557888-B2 | Polymerizable compositions with improved through-curing depth | IVOCLAR VIVADENT AG (LI) | 2013-10-15 | — | — | US | disclosed |
| US-8557888-B2 | Polymerizable compositions with improved through-curing depth | IVOCLAR VIVADENT AG (LI) | 2013-10-15 | — | — | US | disclosed |
| US-20120302657-A1 | Polymerizable compositions with improved through-curing depth | IVOCLAR VIVADENT AG (LI) | 2012-11-29 | — | — | US | disclosed |
| US-20120302657-A1 | Polymerizable compositions with improved through-curing depth | IVOCLAR VIVADENT AG (LI) | 2012-11-29 | — | — | US | disclosed |
| EP-2455059-A1 | Polymerisable compound having improved hardening depth | Ivoclar Vivadent AG (LI) | 2012-05-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120302657-A1 | Polymerizable compositions with improved through-curing depth | NR4A2, NR2C2, NOS2 | EPHX1 1478/4885CES2 2396/4885CES1 4457/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.